vs

Side-by-side financial comparison of First American Financial Corp (FAF) and Steris (STE). Click either name above to swap in a different company.

First American Financial Corp is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.4× Steris). Steris runs the higher net margin — 12.9% vs 10.3%, a 2.6% gap on every dollar of revenue. On growth, First American Financial Corp posted the faster year-over-year revenue change (21.6% vs 9.2%). First American Financial Corp produced more free cash flow last quarter ($324.5M vs $199.5M). Over the past eight quarters, First American Financial Corp's revenue compounded faster (19.9% CAGR vs 15.8%).

First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

FAF vs STE — Head-to-Head

Bigger by revenue
FAF
FAF
1.4× larger
FAF
$2.0B
$1.5B
STE
Growing faster (revenue YoY)
FAF
FAF
+12.5% gap
FAF
21.6%
9.2%
STE
Higher net margin
STE
STE
2.6% more per $
STE
12.9%
10.3%
FAF
More free cash flow
FAF
FAF
$125.0M more FCF
FAF
$324.5M
$199.5M
STE
Faster 2-yr revenue CAGR
FAF
FAF
Annualised
FAF
19.9%
15.8%
STE

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
FAF
FAF
STE
STE
Revenue
$2.0B
$1.5B
Net Profit
$211.9M
$192.9M
Gross Margin
43.8%
Operating Margin
14.0%
18.3%
Net Margin
10.3%
12.9%
Revenue YoY
21.6%
9.2%
Net Profit YoY
192.7%
11.2%
EPS (diluted)
$2.04
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FAF
FAF
STE
STE
Q4 25
$2.0B
$1.5B
Q3 25
$2.0B
$1.5B
Q2 25
$1.8B
$1.4B
Q1 25
$1.6B
$1.5B
Q4 24
$1.7B
$1.4B
Q3 24
$1.4B
$1.3B
Q2 24
$1.6B
$1.3B
Q1 24
$1.4B
$1.1B
Net Profit
FAF
FAF
STE
STE
Q4 25
$211.9M
$192.9M
Q3 25
$189.6M
$191.9M
Q2 25
$146.1M
$177.4M
Q1 25
$74.2M
$145.7M
Q4 24
$72.4M
$173.5M
Q3 24
$-104.0M
$150.0M
Q2 24
$116.0M
$145.4M
Q1 24
$46.7M
$-1.4M
Gross Margin
FAF
FAF
STE
STE
Q4 25
43.8%
Q3 25
44.2%
Q2 25
45.1%
Q1 25
43.3%
Q4 24
44.5%
Q3 24
43.6%
Q2 24
44.7%
Q1 24
40.2%
Operating Margin
FAF
FAF
STE
STE
Q4 25
14.0%
18.3%
Q3 25
12.5%
18.2%
Q2 25
10.6%
17.7%
Q1 25
6.1%
14.6%
Q4 24
5.9%
17.9%
Q3 24
-10.3%
16.5%
Q2 24
9.4%
14.5%
Q1 24
4.1%
22.0%
Net Margin
FAF
FAF
STE
STE
Q4 25
10.3%
12.9%
Q3 25
9.6%
13.1%
Q2 25
7.9%
12.8%
Q1 25
4.7%
9.8%
Q4 24
4.3%
12.7%
Q3 24
-7.4%
11.3%
Q2 24
7.2%
11.4%
Q1 24
3.3%
-0.1%
EPS (diluted)
FAF
FAF
STE
STE
Q4 25
$2.04
$1.96
Q3 25
$1.84
$1.94
Q2 25
$1.41
$1.79
Q1 25
$0.71
$1.48
Q4 24
$0.70
$1.75
Q3 24
$-1.00
$1.51
Q2 24
$1.11
$1.46
Q1 24
$0.45
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FAF
FAF
STE
STE
Cash + ST InvestmentsLiquidity on hand
$1.4B
$423.7M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$5.5B
$7.2B
Total Assets
$16.2B
$10.6B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FAF
FAF
STE
STE
Q4 25
$1.4B
$423.7M
Q3 25
$2.9B
$319.2M
Q2 25
$2.0B
$279.7M
Q1 25
$2.0B
$171.7M
Q4 24
$1.7B
$155.2M
Q3 24
$3.0B
$172.2M
Q2 24
$2.0B
$198.3M
Q1 24
$1.5B
$207.0M
Total Debt
FAF
FAF
STE
STE
Q4 25
$1.9B
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$1.9B
Q4 24
$2.0B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$3.1B
Stockholders' Equity
FAF
FAF
STE
STE
Q4 25
$5.5B
$7.2B
Q3 25
$5.3B
$7.0B
Q2 25
$5.1B
$7.0B
Q1 25
$5.0B
$6.6B
Q4 24
$4.9B
$6.4B
Q3 24
$5.1B
$6.6B
Q2 24
$4.8B
$6.4B
Q1 24
$4.8B
$6.3B
Total Assets
FAF
FAF
STE
STE
Q4 25
$16.2B
$10.6B
Q3 25
$17.6B
$10.4B
Q2 25
$16.3B
$10.4B
Q1 25
$15.5B
$10.1B
Q4 24
$14.9B
$10.0B
Q3 24
$16.6B
$10.2B
Q2 24
$15.2B
$10.1B
Q1 24
$14.7B
$11.1B
Debt / Equity
FAF
FAF
STE
STE
Q4 25
0.27×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.33×
Q2 24
0.35×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FAF
FAF
STE
STE
Operating Cash FlowLast quarter
$369.3M
$298.2M
Free Cash FlowOCF − Capex
$324.5M
$199.5M
FCF MarginFCF / Revenue
15.8%
13.3%
Capex IntensityCapex / Revenue
2.2%
6.6%
Cash ConversionOCF / Net Profit
1.74×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$762.5M
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FAF
FAF
STE
STE
Q4 25
$369.3M
$298.2M
Q3 25
$272.5M
$287.8M
Q2 25
$361.8M
$420.0M
Q1 25
$-52.8M
$260.8M
Q4 24
$324.6M
$332.8M
Q3 24
$236.9M
$250.7M
Q2 24
$266.7M
$303.7M
Q1 24
$69.3M
$254.8M
Free Cash Flow
FAF
FAF
STE
STE
Q4 25
$324.5M
$199.5M
Q3 25
$223.1M
$201.3M
Q2 25
$309.4M
$326.4M
Q1 25
$-94.5M
$189.9M
Q4 24
$266.2M
$243.6M
Q3 24
$185.4M
$148.8M
Q2 24
$210.0M
$195.7M
Q1 24
$17.6M
$163.3M
FCF Margin
FAF
FAF
STE
STE
Q4 25
15.8%
13.3%
Q3 25
11.3%
13.8%
Q2 25
16.8%
23.5%
Q1 25
-6.0%
12.8%
Q4 24
15.8%
17.8%
Q3 24
13.2%
11.2%
Q2 24
13.0%
15.3%
Q1 24
1.2%
14.6%
Capex Intensity
FAF
FAF
STE
STE
Q4 25
2.2%
6.6%
Q3 25
2.5%
5.9%
Q2 25
2.8%
6.7%
Q1 25
2.6%
4.8%
Q4 24
3.5%
6.5%
Q3 24
3.7%
7.7%
Q2 24
3.5%
8.4%
Q1 24
3.6%
8.2%
Cash Conversion
FAF
FAF
STE
STE
Q4 25
1.74×
1.55×
Q3 25
1.44×
1.50×
Q2 25
2.48×
2.37×
Q1 25
-0.71×
1.79×
Q4 24
4.48×
1.92×
Q3 24
1.67×
Q2 24
2.30×
2.09×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FAF
FAF

Title Insurance And Services$1.9B94%
Home Warranty$110.3M5%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons